14 Percent of Young Diabetics Have ADHD: Study Reveals High Rates of Neurodivergence in Type 2 Diabetes
Analysis of 4.2 million patients from the TriNetX network finds twice the rate of ADHD and triple the rate of autism among those diagnosed before age 20.
As the incidence of type 2 diabetes mellitus accelerates among younger populations, clinicians are increasingly scrutinizing the comorbid conditions that accompany this metabolic disorder. A recent analysis presented at the annual meeting of the European Association for the Study of Diabetes in Milan has brought a specific neurodevelopmental correlation into sharp focus. Researchers from the University of Leicester Diabetes Research Center and the NIHR Biomedical Research Center in Leicester have identified that individuals diagnosed with type 2 diabetes at a younger age are significantly more likely to exhibit neurodivergent traits. This finding suggests that the traditional narrative of type 2 diabetes as a condition of middle age may require a more nuanced understanding.
For the purposes of this discussion, we must look at the evidence with clinical precision. The study in question utilized data from the TriNetX US collaborative network, a massive health care database. The authors examined patient records for 4.2 million individuals newly diagnosed with type 2 diabetes between March 2006 and March 2026. To ensure the findings were not skewed by demographic variables, these patients were matched by age, year of birth, sex, ethnicity, and race to a control group of 17.1 million people without type 2 diabetes. This matching process resulted in 3.4 million matched pairs younger than 80 years of age being included in the final analysis. Such a large sample size provides a robust backdrop for observing trends, although it is important to remember that this remains an observational study.
The data revealed a striking disparity in the prevalence of attention-deficit/hyperactivity disorder, or ADHD. Among individuals diagnosed with type 2 diabetes before the age of 20, the prevalence of ADHD reached 14.4 percent. Contrast this with the control group of similar age. The prevalence of ADHD in that group was 6.9 percent. In epidemiological terms, this indicates that children and adolescents with early-onset type 2 diabetes are more than twice as likely to have a diagnosis of ADHD compared to their peers without diabetes. This association generally held true across age groups, though the relative risk diminished in older demographics. For instance, among those diagnosed with type 2 diabetes between the ages of 70 and 79, the prevalence was 0.25 percent compared to 0.18 percent in the control group.
Similarly, the prevalence of autism spectrum disorder showed a pronounced elevation in the younger diabetic cohort. The study found that 5.72 percent of people with early-onset type 2 diabetes were also on the autism spectrum. In comparison, the prevalence among those without the condition was 1.79 percent. This represents a more than threefold increase in relative risk. However, like the data for ADHD, the prevalence of autism in the older age bracket was significantly lower, hovering around 0.01 percent in both groups. The researchers also noted that dyslexia and dyspraxia were more prevalent among younger patients with type 2 diabetes, with individuals with the condition being about twice as likely to have dyslexia as those without it.
The lead author, Dr. Jonathan Goldney of the University of Leicester, emphasized that these findings should be interpreted with a physician's caution. He noted that the association does not imply that every person with ADHD or autism will inevitably develop type 2 diabetes. However, the data highlights a growing population that may be underserved by current health systems. Dr. Goldney stated that health systems are failing to fully meet the needs of people living with both early-onset type 2 diabetes and neurodiversity. He pointed out that neurodivergent people and those with early-onset diabetes face unique challenges when navigating busy healthcare environments and managing their condition.
When we consider the burden of this diagnosis, the implications for long-term outcomes become clear. Being diagnosed with type 2 diabetes at a younger age means a longer lifetime exposure to the condition. This increased duration is associated with a higher risk of serious complications and early mortality. Compounding this is the reality that managing diabetes requires significant lifestyle changes and ongoing engagement with the healthcare system. For neurodivergent individuals, who may struggle with communication barriers or sensory overload in clinical settings, these demands can be overwhelming. Stigma and the competing demands of early adulthood further complicate the picture.
The authors speculate on the biological underpinnings of this association. Several factors may contribute to the link, including lower levels of physical activity, sleep difficulties, and the use of specific medications. Mental health conditions were also noted as a potential contributing factor. Furthermore, the researchers suggested that factors earlier in life, such as maternal diabetes, may influence neurodevelopmental outcomes and later cardiometabolic risk in children. This line of inquiry highlights the complexity of metabolic health and its intersection with the brain.
It is vital to acknowledge the limitations of this study to maintain scientific integrity. The observational design means we cannot definitively establish cause and effect. There are likely confounding factors that were not measured in the data that could explain the observed associations. Additionally, the reliance on anonymized hospital records introduces the possibility of errors. The study population was drawn from those who had attended a hospital, which may not be fully representative of the wider population and could exclude healthier individuals. This selection bias may affect prevalence estimates, particularly for neurodivergent conditions that are often underdiagnosed in the general public.
Despite these limitations, the findings offer a crucial call to action for healthcare providers. The authors underscore the importance of considering neurodiversity when planning clinical services and support for those with early-onset type 2 diabetes. Providing healthcare in a way that is suitable for neurodivergent individuals is critical for making care accessible. Future studies should explore the specific factors underlying this association and determine if tailored diabetes care can improve health outcomes for this distinct patient population.
First reported by Medical Xpress.
More in Health & Nutrition
- Long-term opioid use fails to alleviate chronic back pain, Northwestern University study suggests
Researchers identified distinct brain activity patterns and molecular markers that may guide future treatments for pain management and opioid tapering.
- Human tau seeds trigger disease-specific shapes in mouse brains, new study finds
Study in Nature shows that injectable human tau aggregates from Alzheimer’s and corticobasal degeneration template their 3D folds onto mouse tau, supporting the prion-like seeding model.
- Menopause Largely Missing from Electronic Health Records Despite Its Health Impact
study of nearly 240,000 women finds only 12% of electronic records include menopause status, even though over half reported being in transition.